Karl Utermohlen

Karl Utermohlen

InvestorPlace Writer

Recent Articles

Bilibili Stock Shoots Higher on Strong Q2 Results

By Karl Utermohlen, InvestorPlace Writer

Bilibili stock (BILI) was skyrocketing on Tuesday as the company reported its fiscal second-quarter results, which included an earnings and revenue beat.

Children’s Advil Recall 2018: Check Your Medicine Cabinet

By Karl Utermohlen, InvestorPlace Writer

A children's Advil recall has been issued by Pfizer (PFE) as the company hopes to reduce the chances of the medicine causing an overdose.

Leaving Netflix in August 2018: 23 Things to Watch Before They Go

By Karl Utermohlen, InvestorPlace Writer

We have compiled a list of what's leaving Netflix in August 2018, which includes 'Casino,' 'Batman Begins,' the original 'Ghostbusters' and more.

Why Pfizer (PFE) Stock Turned South Today

By Karl Utermohlen, InvestorPlace Writer

Pfizer stock (PFE) was down nearly 2% by day's end as the company unveiled positive results of one of its drug's clinical trials, but they still have room for improvement.

Moosejaw Opens Up Shop on Walmart.com (WMT)

By Karl Utermohlen, InvestorPlace Writer

Walmart.com (WMT) has started listing Moosejaw items, which is an outdoor retail brand that is one of the many companies it acquired recently as it seeks to scale up.

Load More